Browsing by author "Long, Georgina V."
Sort by:
Title A-Z
-
Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews
Livingstone, Ann; Dempsey, Kathy; Stockler, Martin R.; Howard, Kirsten; Long, Georgina V.; Carlino, Matteo S.; Menzies, Alexander M.; Morton, Rachael L.Published 2021Background Adjuvant immunotherapy is revolutionising care for patients with resected stage III and IV melanoma. However, immunotherapy may be associated with toxicity, making treatment decisions complicated. This study ...Open AccessArticle -
Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods study
Rapport, Frances; Smith, Andrea L.; Cust, Anne E.; Mann, Graham J.; Watts, Caroline G.; Gyorki, David E.; Henderson, Michael; Hong, Angela M.; Kelly, John W.; Long, Georgina V.; Mar, Victoria J.; Morton, Rachael L.; Saw, Robyn P.M.; Scolyer, Richard A.; Spillane, Andrew J.; Thompson, John F.; Braithwaite, JeffreyPublished 2020Introduction Sentinel lymph node biopsy (SLNB) is a diagnostic procedure developed in the 1990s. It is currently used to stage patients with primary cutaneous melanoma, provide prognostic information and guide management. ...Open AccessArticle -
Management of resected stage III/IV melanoma with adjuvant immunotherapy.
Johnson, Rebecca; Atkinson, Victoria; Bhave, Prachi; Weppler, Alison Margaret; Peters, Geoffrey David; Abed, Afaf; Lyle, Megan; Khattak, Muhammad Adnan; Haydon, Andrew Mark; Carlino, Matteo S.; Sandhu, Shahneen Kaur; Long, Georgina V.; Menzies, Alexander M.Published 2021Background: Adjuvant anti-PD1 therapy reduces the risk of recurrence in resected stage III/IV melanoma and is now standard care. Limited data exist beyond registration trials. We sought to explore the use of adjuvant ...Article
Sort by:
Title A-Z